SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ImmunoCellular Therapeutics, Ltd Announces Clearance of IND Application for Phase I Study of Company’s Second Vaccine Product Candidate in Recurrent GBM
Your Message